Target intelligence / Profile preview

Cytochrome c oxidase assembly factor 7 (COA7)

Target
COA7
Molecular classification
Other, Mitochondrial protein, Protein assembly factor, Sel1-like repeat protein
01

Overview

Cytochrome c oxidase assembly factor 7 (COA7) is a soluble mitochondrial intermembrane space protein required for the proper assembly and stability of cytochrome c oxidase (complex IV) in the mitochondrial respiratory chain[1][2][3]. The protein contains Sel1-like repeat domains and forms part of the molecular machinery that enables the biogenesis of functional respiratory complex IV, and to some extent is implicated in the assembly of complexes I and III as well[1][2]. Pathogenic variants in the *COA7* gene are causative for complex IV deficiency, clinically manifesting as mitochondrial myopathy, spinocerebellar ataxia with axonal neuropathy, and leukoencephalopathy of variable severity, ranging from isolated myopathy to early-onset developmental regression[1][2][3]. COA7 interacts with the MIA40 import pathway in the mitochondrial intermembrane space, where it is stabilized through disulfide bonds[2]. There are currently no approved drugs directly targeting COA7 or its pathway, but proteasome inhibition has been proposed as a way to rescue COA7 stability and function in cellular models[2].

Other names
C1orf163RESA1SELRC1SCAN3Beta-lactamase hcp-like proteinRespiratory chain assembly factor 1Sel1 repeat-containing protein 1beta-lactamase hcp-like proteinrespiratory chain assembly 1
02

Biological functions

Assembly of cytochrome c oxidase (complex IV) in the mitochondrial respiratory chainMaintenance of mitochondrial respiratory chain functionInteraction with mitochondrial import machinery (MIA40 pathway)
03

Disease associations

Mitochondrial diseaseSpinocerebellar ataxiaNeuropathy (e.g. axonal sensorimotor)Mitochondrial myopathyLeukoencephalopathy
04

Safety considerations

Loss-of-function or pathogenic variants result in multisystem mitochondrial disorders with neurological involvement, suggesting challenges for gene or enzyme replacement therapies
05

Biomarkers

Mutations or deletions in the *COA7* gene as a molecular genetic marker for mitochondrial respiratory chain disorders, especially complex IV deficiencyDecreased activity of cytochrome c oxidase (complex IV) in patient tissues

Beyond the preview

Go deeper on Cytochrome c oxidase assembly factor 7 (COA7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c oxidase assembly factor 7 (COA7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call